JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M107289200 on January 31, 2002

J. Biol. Chem., Vol. 277, Issue 16, 14299-14305, April 19, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/16/14299    most recent
M107289200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rubio, L. M.
Right arrow Articles by Ludden, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rubio, L. M.
Right arrow Articles by Ludden, P. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cloning and Mutational Analysis of the gamma  Gene from Azotobacter vinelandii Defines a New Family of Proteins Capable of Metallocluster Binding and Protein Stabilization*

Luis M. RubioDagger , Priya RangarajDagger , Mary J. Homer§, Gary P. Roberts§, and Paul W. LuddenDagger ||

From the Departments of Dagger  Biochemistry and § Bacteriology and the Center for the Study of Nitrogen Fixation, College of Agricultural and Life Sciences, University of Wisconsin-Madison, Madison, Wisconsin 53706

Received for publication, July 31, 2001, and in revised form, January 25, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
CONCLUSION
REFERENCES

Dinitrogenase is a heterotetrameric (alpha 2beta 2) enzyme that catalyzes the reduction of dinitrogen to ammonium and contains the iron-molybdenum cofactor (FeMo-co) at its active site. Certain Azotobacter vinelandii mutant strains unable to synthesize FeMo-co accumulate an apo form of dinitrogenase (lacking FeMo-co), with a subunit composition alpha 2beta 2gamma 2, which can be activated in vitro by the addition of FeMo-co. The gamma  protein is able to bind FeMo-co or apodinitrogenase independently, leading to the suggestion that it facilitates FeMo-co insertion into the apoenzyme. In this work, the non-nif gene encoding the gamma  subunit (nafY) has been cloned, sequenced, and found to encode a NifY-like protein. This finding, together with a wealth of knowledge on the biochemistry of proteins involved in FeMo-co and FeV-co biosyntheses, allows us to define a new family of iron and molybdenum (or vanadium) cluster-binding proteins that includes NifY, NifX, VnfX, and now gamma . In vitro FeMo-co insertion experiments presented in this work demonstrate that gamma  stabilizes apodinitrogenase in the conformation required to be fully activable by the cofactor. Supporting this conclusion, we show that strains containing mutations in both nafY and nifX are severely affected in diazotrophic growth and extractable dinitrogenase activity when cultured under conditions that are likely to occur in natural environments. This finding reveals the physiological importance of the apodinitrogenase-stabilizing role of which both proteins are capable. The relationship between the metal cluster binding capabilities of this new family of proteins and the ability of some of them to stabilize an apoenzyme is still an open matter.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
CONCLUSION
REFERENCES

Nitrogenase catalyzes the reduction of nitrogen gas to ammonium, in an ATP- and reductant-dependent reaction. It is one of the best characterized metalloenzymes and is an excellent model for elucidating metalloprotein assembly. Nitrogenase is composed of two oxygen-labile metalloproteins: dinitrogenase and dinitrogenase reductase (1, 2). Dinitrogenase (also termed component I or molybdenum-iron protein) is a 240-kDa alpha 2beta 2 tetramer of the nifD and nifK gene products (3). Each alpha beta nitrogenase dimer contains an iron-molybdenum cofactor (FeMo-co)1and a P cluster (3, 4). Dinitrogenase reductase (also termed component II or iron protein) is a 60-kDa alpha 2 dimer of the nifH gene product which contains a single 4Fe-4S center coordinated between the two subunits (5). NifH has at least three roles in the nitrogenase enzyme system (6): first, it serves as electron donor to nitrogenase; second, it participates in the biosynthesis of FeMo-co; and third, it is required for maturation of apodinitrogenase to a FeMo-co-activable form.

The genes that encode dinitrogenase (nifD and nifK) are not required for FeMo-co biosynthesis, suggesting that FeMo-co is assembled elsewhere in the cell and is then inserted into apodinitrogenase (7). It is known that the products of at least seven nitrogen fixation (nif) genes, nifB, nifE, nifH, nifN, nifQ, nifV, and nifX, are involved in the biosynthesis of FeMo-co (8). Azotobacter vinelandii or Klebsiella pneumoniae strains with mutations in nifB, nifN, or nifE produce a FeMo-co-deficient hexameric (alpha 2beta 2gamma 2) apodinitrogenase that can be activated in vitro by the simple addition of purified FeMo-co (9, 10). On the other hand, apodinitrogenase from Delta nifH mutants has a tetrameric composition (alpha 2beta 2) and requires some type of NifH- and MgATP-dependent maturation that, in turn, promotes the association of the gamma  subunit and leads to the form that is competent for FeMo-co activation (11, 12).

In vitro studies on crude extracts of an A. vinelandii nifB mutant demonstrated that the gamma  protein specifically binds to free FeMo-co and to apodinitrogenase, consistent with a role in FeMo-co insertion (13). However Christiansen et al. (14) have reported that pure preparations of His-tagged apodinitrogenase from a nifB mutant strain lacked the gamma  subunit but still could be activated to 80% of the theoretical value by the simple addition of FeMo-co, which suggests a role for gamma  other than that of a FeMo-co insertase. As they pointed out, the solution to this controversy would require the inactivation of the gamma  gene.

In K. pneumoniae the third subunit in the hexameric apodinitrogenase is the product of the nifY gene (10, 15). However, this is not the case in A. vinelandii, where the gamma -encoding gene is not in the nif gene clusters. Although A. vinelandii contains a nifY gene there is no mutant phenotype associated with its inactivation (16).

In this work, we have cloned and inactivated the A. vinelandii gene encoding the gamma  protein. In vivo and in vitro results presented here indicate that gamma  stabilizes apodinitrogenase in an open (FeMo-co activable) conformation; by contrast, our results do not support a role for gamma  as an essential FeMo-co insertase.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
CONCLUSION
REFERENCES

Materials-- Sodium dithionite was from Fluka. Leupeptin, phenylmethylsulfonyl fluoride, phosphocreatine, creatine phosphokinase, and ATP were from Sigma. Tris and glycine were from Fisher Scientific. Nitrocellulose and polyvinylidene difluoride membranes were from Millipore. Acrylamide/bisacrylamide and the equipment for SDS-PAGE were from Bio-Rad. Ammonium tetrathiomolybdate ((NH4)2MoS4) was a gift from D. Coucouvanis (University of Michigan, Ann Arbor).

Buffers-- 25 mM Tris·HCl, pH 7.5, was used throughout this work. All buffers for protein analysis were sparged with purified N2 for 20-30 min, and sodium dithionite was added to a final concentration of 1 mM. Buffers used for obtaining A. vinelandii cell-free extracts contained 0.5 µg/ml leupeptin and 0.2 mM phenylmethylsulfonyl fluoride.

Strains and Growth Conditions-- A. vinelandii strains DJ (wild type), DJ166 (Delta nifX), and DJ208 (Delta nifY) were obtained from D. R. Dean, Department of Biochemistry, Virginia Technical Institute, Blacksburg, Virginia. Strain UW45 (nifB) has been described previously (17). Growth in the presence of molybdate, nif derepression, and cell breakage have been described (18). For growth on plates, the medium was solidified with separately autoclaved 1.5% agar solution. 0.5 µg/ml kanamycin, 0.25 µg/ml streptomycin, 10 µg/ml spectinomycin, and 5 µg/ml rifampin were added as required. Escherichia coli DH5alpha was grown in Luria-Bertani medium at 37 °C with shaking (200 rpm). For growth of E. coli on plates, medium solidified with 1.5% agar was used. Antibiotics were used at standard concentrations (19).

For growth rate determinations, strains were grown at 30 °C on Burk's modified medium (designated as standard growth conditions) or at 37 °C on Burk's modified medium not supplemented with molybdate (designated as stressing growth conditions). When a fixed nitrogen source was required, ammonium acetate was added to a final concentration of 29 mM. Growth was estimated from the absorbance of the cultures at 600 nm, using a Shimadzu UV1201V spectrophotometer. The growth rate constant corresponds to ln2/td, where td represents the doubling time.

Cloning of the gamma -Encoding Gene (nafY)-- The N-terminal amino acid sequence for gamma  (VTPVNMSRETALRIALAARALPGTTVGQLL) was obtained from a preparation of partially purified alpha 2beta 2gamma 2 apodinitrogenase (see below). Degenerate oligonucleotides 5'-GTNACNCCNGTNATCATG-3' and 5'-CTGICCIACGGTGGTICCIGG-3' were designed, based on the N-terminal amino acid sequence, and were used as primers in a PCR to amplify an 81-bp DNA fragment from the chromosome of A. vinelandii. After sequencing the 81-bp fragment, oligonucleotides 5'-CGCCCTGGCTGCCAGGGCTTTG-3' (complementary to nucleotides 42-63 with respect to the translation start of the gamma  gene, termed nafY for nitrogenase accessory factor Y) and 5'-ATGCGCAGAGCGGTTTCGCGAC-3' (complementary to nucleotides 41-20 with respect to the translation start of nafY) were used as primers in a reverse PCR. SalI-digested and religated chromosomic DNA from A. vinelandii was used as template for this reaction. A 1.5-kbp PCR product was obtained, ligated into pGEM-T, sequenced, and digested with BglII and SalI to generate a 1,236-bp DNA fragment that was finally ligated into pUK21 to render plasmid pRHB20. Plasmid pRHB20 contains sequences 5' of nafY from the A. vinelandii chromosome. A. vinelandii strain UW139 was generated by transforming DJ strain with plasmid pRHB20 and selecting for single recombinants on plates containing ammonium acetate- and kanamycin-supplemented Burk's medium. Genomic DNA from strain UW139 was digested with either BamHI or XhoI, religated, and used to transform E. coli DH5alpha , rendering plasmids pRHB21 and pRHB24, respectively. Plasmid pRHB21 contains approx 14 kbp of A. vinelandii DNA sequences 5' of nafY, whereas plasmid pRHB24 contains 1.2 kbp of sequences 5' of nafY along with nafY and approx 16 kbp of 3'-sequences (see Fig. 1).

Plasmid Constructions and DNA Manipulations-- Plasmid constructions, PCR, and transformation of E. coli were carried out by standard methods (19). A computer search for homologies was made using the BLAST algorithm (20). Isolation of DNA from A. vinelandii strains was carried out using the DNAeasyTM Tissue Kit (Qiagen).

RNA Isolation and Northern Analysis-- For isolation of RNA, A. vinelandii strains grown in modified Burk's medium containing fixed nitrogen (29 mM ammonium acetate) were derepressed for nitrogenase as described (21). Isolation of RNA from A. vinelandii strains was performed using the RNeasyTM Midi Kit (Qiagen). For Northern analysis, 10-µg portions of RNA samples were electrophoresed in a denaturing formaldehyde gel and transferred to a positively charged nylon membrane (Millipore). Prehybridization and hybridization were performed in the presence of 50% formamide at 42 °C. A PCR-amplified DNA fragment, covering the entire nafY, was used as probe after labeling with Prime-It II Random Primer Labeling Kit (Stratagene) and [alpha -32P]dCTP.

Mutagenesis of A. vinelandii Genes-- Procedures for A. vinelandii transformation (22) and gene replacement (23) have been described. Plasmid pRHB25 contains a 3.4-BglII DNA fragment from plasmid pRHB24 which includes a portion of rnfH, nafY, and additional 3'-sequences. Plasmids pRHB29a and pRHB29b were generated by substitution of a kanamycin resistance cassette for a 231-bp SalI fragment within nafY in plasmid pRHB25. The kanamycin resistance gene in the cassette, obtained from plasmid pUC4K, was in the same orientation as nafY in plasmid pRHB29a and in the opposite orientation from nafY in plasmid pRHB29b. UW146 was generated by transformation of strain UW45 with plasmid pRHB29b. Strains UW141, UW147, and UW154 were generated by transformation of strains DJ, DJ166, and DJ208 with plasmid pRHB29a, respectively, followed by selection of a Kanr phenotype. Plasmid pRHB28 was generated after removing the 231-bp SalI fragment from pRHB25 described above, to produce an in-frame deletion within nafY. Strains UW149, UW156, and UW158 were generated by transformation of strains UW141, UW154 and UW147 with plasmid pRHB28, respectively, and scored for the Kans phenotype. UW166 was generated by transformation of UW156 with plasmid pRHB44a, which contains nifX disrupted by an insertion of a kanamycin resistance cassette at the internal Eco47III site to nifX. The kanamycin resistance gene in the cassette, obtained from plasmid pUC4K, was in the same orientation as nifX. Plasmid pRHB42 contains a 1.5-kbp SalI fragment from pRHB24 which includes a portion of rnfG along with rnfE, rnfH, and a portion of nafY. Plasmid pRHB43 was generated by insertion of the Omega  interposon, from plasmid pHP45Omega , into the unique BglII site within rnfH in pRHB42. UW165 was generated by transformation of strain DJ with plasmid pRHB43. All generated mutations were checked by PCR to confirm that double recombination and segregation events occurred.

In Vitro Dinitrogenase and Dinitrogenase Reductase Activities-- Dinitrogenase and dinitrogenase reductase activities in cell-free extracts were obtained after titration with an excess of the complementary component as described (24). The specific activity of each protein is defined as nmol of ethylene formed/min/mg of protein.

Activation of Apodinitrogenase with Purified FeMo-co (in Vitro FeMo-co Insertion Assay)-- FeMo-co was prepared in N-methylformamide as described (25). 9-ml serum vials were evacuated and flushed repeatedly with purified argon and rinsed with anaerobic 25 mM Tris·HCl buffer, pH 7.5. The following were then added to the vials: 100 µl of Tris·HCl buffer, 200 µl of UW45 or UW146 cell-free extracts (approx 3 mg of protein), and 2 or 10 µl of a solution containing FeMo-co (equivalent to 0.1 and 0.5 nmol of Mo, respectively). The mixtures were incubated for 30 min at 30 °C after which 0.8 ml of ATP-regenerating mixture (containing 3.6 mM ATP, 6.3 mM MgCl2, 51 mM phosphocreatine, 20 units/ml creatine phosphokinase, and 6.3 mM sodium dithionite) and an excess of purified NifH (0.2 mg of protein) were added. Nitrogenase activity was then quantitated by acetylene reduction as described (26).

For the in vitro FeMo-co insertion time course experiments, 21-ml serum vials were evacuated and flushed repeatedly with purified argon and rinsed with anaerobic Tris·HCl buffer. The following were then added to the vials: 0.7 ml of Tris·HCl buffer, 1.4 ml of UW45 or UW146 cell-free extracts (approx 21 mg of protein), and 70 µl of a solution containing FeMo-co (equivalent to 3.5 nmol of molybdenum). The mixtures were incubated at 30 °C, and 0.2-ml aliquots were removed at different times and injected into anaerobic 9-ml serum vials containing 40 nmol of (NH4)2MoS4 to prevent further insertion of FeMo-co into apodinitrogenase. The vials were incubated for at least 10 min at room temperature, and 0.8 ml of ATP-regenerating mixture and an excess of purified NifH (0.2 mg of protein) were added. Nitrogenase activity was then quantitated by acetylene reduction as described (26).

SDS-PAGE and Immunoblot Analysis-- The procedure for SDS-PAGE has been described (27). Immunoblot analysis was performed as described by Brandner et al. (28).

Preparation of gamma  Protein for N-terminal Sequencing-- A preparation of partially purified hexameric apodinitrogenase (alpha 2beta 2gamma 2) from strain UW45, containing about 12 µg of protein, was subjected to SDS-PAGE and transferred to a polyvinylidene difluoride membrane. The gamma  protein band was excised from the membrane and used for N-terminal sequence at the Protein/Peptide Micro Analytical Laboratory of the California Institute of Technology.

Protein Assays---Protein concentrations were determined by the bicinchoninic acid method using bovine serum albumin as standard (29).

    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
CONCLUSION
REFERENCES

Cloning of the Gene Encoding the gamma  Protein from A. vinelandii-- A combination of PCR and reverse PCR techniques was used to isolate the gene encoding gamma  from A. vinelandii genomic DNA (for details see "Experimental Procedures"). The cloning procedure resulted in the recovery of plasmids pRHB21 and pRHB24. pRHB21 contains approx 14 kbp of A. vinelandii DNA sequence 5' of the gamma -encoding gene (nafY), whereas pRHB24 contains 1.2 kbp of sequence 5' of nafY along with nafY and approx 16 kbp of 3'-sequences (Fig. 1). Sequencing of the 1.2-kbp SalI-BglII fragment located 5' of nafY revealed the presence of three ORFs, designated ORF1, ORF2, and ORF3, which would encode polypeptides showing homology to RnfG, RnfE, and RnfH polypeptides from Rhodobacter capsulatus, respectively (30). In R. capsulatus, the Rnf polypeptides are required in vivo for nitrogen fixation and are proposed to constitute a membrane complex involved in electron transport to nitrogenase (30, 31). Thus, rnf genes and nafY are clustered in the A. vinelandii chromosome (Fig. 1). No other ORFs were found in the 500 bp 3' of nafY in plasmid pRHB24, strongly suggesting that nafY is the last gene of the cluster.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 1.   Structure of the genomic region of A. vinelandii which contains nafY and several rnf genes. The location of a deletion within nafY and an Omega  interposon insertion within rnfH are indicated together with the UW denomination of the resultant mutant strain. Thick lines in the upper part of the figure indicate the regions covered by plasmids pRHB20, pRHB21, and pRHB24. B, BamHI; Bg, BglII; S, SalI; X, XhoI.

nafY Encodes a NifY-like Protein-- Fig. 2 compares the amino acid sequences of gamma  with some gamma  homologs found in protein data bases. It is clear that nafY encodes a protein that is similar to NifY, NifX, VnfX, and the C-terminal half of NifB from A. vinelandii and other bacterial sources. The actual role of NifY in the A. vinelandii nif system is not known. However, K. pneumoniae NifY is found instead of gamma  as the third subunit in the hexameric apodinitrogenase (10, 15). NifX and VnfX are proteins involved in the biosyntheses of FeMo-co and FeV-co, respectively (8, 32). FeV-co is an iron-vanadium cofactor contained in the vnf-encoded dinitrogenase and functions analogously to FeMo-co of the molybdenum system (33). NifB is required for the three nitrogenase systems (molybdenum-, vanadium-, and iron-only-containing nitrogenases) (34), and its role may be the synthesis of NifB-co, an iron-sulfur cluster that serves as precursor for FeMo-co, FeV-co, and FeFe-co biosyntheses (35). Sequence identity between nifY and nifX gene products from A. vinelandii and K. pneumoniae have been noted before (16), but no functional relationships could be inferred at that time. When sequence identity between NifY/NifX and NifB proteins was noted, a role for NifY/NifX proteins in FeMo-co maturation or stabilization was suggested based on the known role of NifB in FeMo-co biosynthesis (36). Interestingly, the most similar protein in data bases is the recently reported product of a nifY-like gene in the bacterium Pseudomonas stutzeri (GenBank accession no. AJ297529). The physical organization of the rnf region in P. stutzeri (rnfCDGEH-nifY-like-ORF13-ORF12-nifH) somewhat resembles the A. vinelandii organization, where two separate rnfGEH-nafY (this work) and ORF13-ORF12-nifH regions have been found (GenBank accession no. AF014048). Although it is reasonable to believe that there might be a physical linkage between the two regions in the A. vinelandii chromosome, this is unlikely because we have not been able to complement the mutation in A. vinelandii strain DJ54 (Delta nifH) by transformation with plasmids pRHB21 or pRHB24.


View larger version (72K):
[in this window]
[in a new window]
 
Fig. 2.   Amino acid sequence alignment of members of the NafY/NifY/NifX/VnfX family of iron and molybdenum (or vanadium) cluster-binding proteins. The amino acid sequences are indicated by the single letter code. Gaps were introduced for optimal alignments. Circles and asterisks indicate amino acid residues identical or similar in five or more of the aligned proteins, respectively. Only residues 331-468 in the K. pneumoniae NifB sequence are aligned. The entire sequence of all other polypeptides is shown. Av, A. vinelandii; Kp, K. pneumoniae; Ps, P. stutzeri.

Consistent with the sequence similarity among gamma , NifY, NifX, and VnfX polypeptides, in vitro studies provide supporting evidence that they are functionally related because they are able to interact with some intermediates of the FeMo-co or FeV-co biosynthetic pathways. First, the gamma  protein binds FeMo-co (13). Second, NifX and VnfX from A. vinelandii are also able to bind FeMo-co (37),2 as well as NifB-co (32, 37). Third, VnfX is also able to bind a FeV-co precursor (vanadium-containing iron-sulfur cluster) lacking homocitrate (32). Taken together, these lines of evidence indicate that gamma , NifY, NifX, and VnfX constitute a family of iron and molybdenum (or vanadium) cluster-binding proteins.

nafY and rnfH Are Transcribed Independently-- It has been reported that the rnf gene cluster from R. capsulatus is subject to nif regulation and that their products are required in vivo for nitrogen fixation (30). In contrast, nothing is known about regulation of the expression of the rnf gene cluster in A. vinelandii, but it is known that gamma  (NafY) is not the product of a nif gene, nor is it nif coregulated (13). Because rnfH and nafY are clustered in the A. vinelandii chromosome, having an intergenic region of only 24 bp, we wondered whether they are cotranscribed. As a preliminary approach to address this question, the Omega  interposon was inserted into the BglII site located within rnfH to generate a polar mutation (Fig. 1). The Omega  interposon carries transcriptional terminators and has been shown to impair gene expression from promoters 5' of the site of Omega  insertion in a wide range of Gram-negative bacteria (38). Crude extracts were prepared from nif-derepressed cells of wild-type and mutant strain UW165 (rnfH::Omega ) and analyzed by immunoblot of an SDS-gel developed with antibody to gamma  (Fig. 3). The presence of gamma  in the extracts of strain UW165 suggests that a promoter 3' of the Omega  interposon insertion site is driving nafY expression. However, the 80-bp region between the Omega  insertion site and the nafY start codon lacks any obvious promoter sequences and is unable to promote gamma  accumulation when present in a plasmid in E. coli (data not shown). Given the substantial amount of gamma  protein that A. vinelandii cells are able to accumulate (9, 13), the lack of an obvious promoter sequence 5' of nafY is unexpected; nevertheless the result still suggests independent regulation of rnfH and nafY.


View larger version (84K):
[in this window]
[in a new window]
 
Fig. 3.   Immunoblot analysis of gamma  in extracts of DJ, UW165 (rnfH::Omega ), and UW149 (nafY) strains. SDS-gel immunoblot was developed with antibody to gamma . The arrow points to the gamma  protein position. The position and sizes of some molecular mass markers are indicated on the left.

In addition, a approx 1.1-kb RNA species was identified by Northern analysis using a nafY probe (Fig. 4). The observed transcript is of sufficient length to encode the whole NafY and is present in both ammonium-grown and nif-derepressed cells (compare lanes 1 and 2), although it appears to be more abundant in nif-derepressed cells. Consistent with the immunoblot results, cells from strain UW165 (rnfH::Omega , lanes 3 and 4) also contain the 1.1-kb nafY transcript, indicating independent transcription from rnfH. Our Northern analysis does not, however, rule out the presence of additional longer transcripts that could cover part or the whole rnf-nafY cluster.


View larger version (97K):
[in this window]
[in a new window]
 
Fig. 4.   Identification of nafY transcripts from strains DJ (wild-type) and UW165 (rnfH::Omega ). RNA isolated from A. vinelandii cells grown with ammonium (lanes 1 and 3) or derepressed for nitrogen fixation (lanes 2 and 4) was probed with a DNA fragment covering the entire nafY. The arrow points to a approx 1.1-kb nafY transcript. The position and sizes of some molecular mass markers are indicated on the left. The lower panel shows the ethidium bromide staining of total RNA in the samples, carried out as a loading control.

Mutational Analysis of the nafY Gene-- The nafY gene was mutated by creation of a nonpolar in-frame deletion, termed Delta nafY, and the mutation was transferred to the chromosome of A. vinelandii wild-type strain to generate strain UW149 (see "Experimental Procedures"). Immunoblot analysis showed the absence of gamma  in extracts of UW149 (Fig. 3). As presented in Table I, molybdate-dependent diazotrophic growth rate was minimally affected in strain UW149. Also, crude extracts of strain UW149 exhibit normal levels of in vitro dinitrogenase and dinitrogenase reductase activities (Table II). These results suggest that the role of gamma  is not essential for diazotrophic growth under standard laboratory conditions, perhaps because some other protein is performing the same function when gamma  is not present.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Growth rates of the wild-type and mutant strains of A. vinelandii using N2 as a sole source of nitrogen

                              
View this table:
[in this window]
[in a new window]
 
Table II
Acetylene reduction activities in extracts of A. vinelandii nafY, nifX, and nifY strains
Values are the averages of at least two assays performed separately. Activities are expressed as nmol of ethylene formed/min/mg of protein. ND means not determined.

To test the possibility of functional redundancy because of the presence of NifY or NifX (which have some sequence and functional similarity as noted above), Delta nafY mutation was transferred to the chromosome of strains DJ208 (Delta nifY) and DJ166 (Delta nifX), generating UW156 (Delta nifYDelta nafY) and UW158 (Delta nifXDelta nafY), respectively. UW166 (Delta nifYDelta nafYnifX::kan) was subsequently constructed by transformation of strain UW156 with plasmid pRHB44a (for details, see "Experimental Procedures"). As in the case of Delta nafY mutant (see above), A. vinelandii Delta nifX and Delta nifY mutants are not impaired for diazotrophic growth under the normal diazotrophic growth conditions (16). A 30% decrease in the growth rates under standard diazotrophic growth conditions was observed in strains bearing Delta nafY or Delta nifX mutations (Table I). On the other hand, the diazotrophic growth rate was unaffected in the Delta nifY mutant. Nitrogenase-derepressed extracts of these mutants were used to determine the effect of combining nafY, nifY, and nifX mutations on the levels of dinitrogenase activity. As shown in Table II, dinitrogenase activity levels are not altered significantly in any of the mutants when grown under standard nitrogen fixation conditions. In short, the data presented in Tables I and II show that when A. vinelandii is grown at 30 °C with sufficient molybdenum, there is no additive effect of mutations in any two or all three of the members of the nafY/nifY/nifX family. In all cases, a small reduction of diazotrophic growth rate is observed, and similar levels of dinitrogenase activity are found in crude extracts. It is possible that in the standard diazotrophic growth conditions used in the laboratory, in vivo FeMo-co synthesis and insertion could be sufficiently good for adequate growth to make the nafY/nifY/nifX function dispensable.

Following this logic, we attempted to force A. vinelandii cells to maintain a stable apodinitrogenase at a higher temperature and in an "open" conformation by reducing FeMo-co availability inside the cell. Thus, A. vinelandii strains carrying mutations in nafY, nifY, and nifX genes were tested for their abilities to grow under conditions of elevated temperature (37 °C) and molybdenum stress. Molybdenum stress refers to cells growing in Burk's medium not supplemented with the standard 10 µM Na2MoO4. A. vinelandii is known to be extremely efficient in scavenging traces of molybdenum from the culture medium (39), and the short-term lack of a molybdenum supplement should not be interpreted as a Mo-free medium. Under these conditions, the combination of mutations in nafY and nifX (UW158) and nafY, nifY, and nifX (UW166) had a profound effect on diazotrophic growth rates (5-fold lower than wild type), whereas UW149 (Delta nafY), DJ166 (Delta nifX), and UW156 (Delta nafYDelta nifY) strains exhibited decreases of approx 35% in their growth rates, and no effect was observed for DJ208 (Delta nifY) (Table I). In contrast, all mutant strains exhibited wild-type growth rates when using ammonium as nitrogen source under the same culturing conditions at 37 °C (data not shown).

The mutation in nafY also had an effect on the levels of extractable dinitrogenase activity when mutant strains were grown under stressing nitrogen fixation conditions (Table II). Dinitrogenase activity in the wild-type strain (DJ) was 60% of the value observed in standard conditions. However, it was severely diminished (2-5% of the values observed in standard conditions) in strains carrying mutations in nafY (UW149), nafY and nifX (UW158), and nafY, nifX, and nifY (UW166). This decrease in the activity of dinitrogenase in nafY mutant strains correlated with the accumulation of lower levels of NifDK polypeptides, as checked by immunoblot (data not shown). It is clear that the function of nafY is very important for dinitrogenase activity when cells are under stressing nitrogen fixation conditions. It is important to note that no ethane was detected during the acetylene reduction assays performed to determine nitrogenase activities under molybdenum stressing conditions. The coproduction of ethylene and ethane from acetylene by nitrogenase is characteristic of alternative molybdenum-independent nitrogenases and, therefore, the result indicates that only the molybdenum-dependent nitrogenase system is present.

Table III shows that the addition of purified FeMo-co to cell extracts of A. vinelandii strains grown under stressing nitrogen fixation conditions did not increase the levels of nitrogenase activity already present in the extracts (compare with values in Table II). The lack of activation by FeMo-co was not fixed by the addition of dinitrogenase reductase to the extract during FeMo-co insertion. Again, nafY mutants showed very small levels of dinitrogenase activity compared with wild type, indicating that nafY mutants do not accumulate substantial amounts of FeMo-co-activable apodinitrogenase in stressing conditions, but they rather have a very unstable form of dinitrogenase.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Effect of the addition of purified FeMo-co to extracts of A. vinelandii nafY, nafYnifX, and nafYnifYnifX strains grown under stressing nitrogen fixation conditions

Taken together these results are consistent with a model in which NafY and NifX, but not NifY, are capable of playing a role in either insertion of FeMo-co into apodinitrogenase or stabilization of apodinitrogenase in an open activable conformation. These two possible roles are likely to be very important under natural environmental conditions, where limiting amounts of molybdenum are available and apodinitrogenase must be maintained and protected in an open (FeMo-co-deficient) conformation. Although we cannot conclusively rule out a role for NafY in the stabilization of FeMo-co inside the cell, no substantial dinitrogenase reactivation is observed when purified FeMo-co is added to cell extracts of nafY mutants grown under stressing conditions.

In Vitro Activation of Apodinitrogenase in Extracts of Strains UW45 and UW146 by Purified FeMo-co-- Because of its ability to bind independently to FeMo-co and to apodinitrogenase, both FeMo-co insertase and chaperone roles have been proposed for the gamma  protein (13). A tetrameric (alpha 2beta 2) His-tagged apodinitrogenase is, however, competent for FeMo-co activation despite lacking gamma  (14). We have compared the FeMo-co-dependent activation properties of gamma -deficient (alpha 2beta 2?) and hexameric (alpha 2beta 2gamma 2) apodinitrogenases present in extracts of strains UW146 (nifBnafY) and UW45 (nifB), respectively. In this work, we will use a question mark in the description of the gamma -deficient apodinitrogenase because we do not yet know its exact subunit composition. To demonstrate that the mutation in nafY is not affecting the accumulation of apodinitrogenase in the extracts of UW146, the same amount of total protein from extracts of UW45 and UW146 was resolved by SDS-PAGE and analyzed by immunoblot, developed with antibodies to dinitrogenase (Fig. 5). The amount of anti-NifDK-reacting material in the immunoblot was then quantified by densitometric analysis and shown as relative numbers in Fig. 5. These data indicate that under standard nitrogen fixation conditions, the nafY mutation does not result in decreased levels of apodinitrogenase in extracts of UW146.


View larger version (60K):
[in this window]
[in a new window]
 
Fig. 5.   Immunoblot of an SDS-gel developed with antibody to dinitrogenase. Crude extracts from two different cultures of UW45 (lanes 1 and 2) and UW146 (lanes 3 and 4) strains were loaded onto an SDS-gel, electrophoresed, transferred to a nitrocellulose membrane, and developed with antibody to dinitrogenase. The relative amount of apodinitrogenase in each sample (numbers shown at the bottom of each lane) was then estimated by scanning the membrane using Personal Densitometer SI from Molecular Dynamics. The position and sizes of some molecular mass markers are indicated on the left.

30 min after the addition of FeMo-co, apodinitrogenase lacking gamma  (UW146) could only be activated to a value of 9.2 nmol of ethylene formed/min/mg of protein, which is 57% of the value seen for the gamma -containing apodinitrogenase from UW45 (see Table IV). UW146 and UW45 extracts contained similar levels of apodinitrogenase (see above) and dinitrogenase reductase activities (23.5 ± 2.8 nmol of ethylene produced/min/mg of protein). These data considered, the evident difference in activation could only be caused either by a lower insertase activity or a lower level of activable apodinitrogenase in extracts of strain UW146. These results are in contrast to the case in K. pneumoniae, where a nifBnifY mutant is severely affected in the levels of FeMo-co-activable apodinitrogenase (10) and in apodinitrogenase antigen as well.3 Fig. 6 illustrates a time course of FeMo-co insertion into apodinitrogenase over a period of 30 min. Apodinitrogenase in extracts of UW45 and UW146 presented a similar activation profile, except that the maximum level of activation is halved in extracts of UW146. It is clear that the lack of gamma  in extracts of UW146 does not limit the rate of FeMo-co insertion during the reaction. Moreover, no enhancement of FeMo-co insertion was obtained by combining extracts of nif-derepressed UW146 cells and ammonium-grown wild-type cells containing gamma  protein, as expected if gamma  were involved in the insertion reaction (data not shown). Thus, the addition of gamma  to the in vitro insertion reaction mixture is not enough to restore the levels of activable apodinitrogenase in UW146 extracts. Results presented in Table IV and Fig. 6 indicate that a lower level of activable apodinitrogenase, and not a defect in FeMo-co insertion, is the main cause of reduced holodinitrogenase reconstitution in extracts of strain UW146. It is very interesting that the value of holodinitrogenase formation from gamma -free apodinitrogenase is about 50% of the value obtained from the gamma -containing enzyme. Experiments to distinguish whether there is only one nonactivable FeMo-co pocket per alpha 2beta 2 apodinitrogenase tetramer or if half of its population is nonactivable by FeMo-co are currently being developed.

                              
View this table:
[in this window]
[in a new window]
 
Table IV
In vitro activation of apodinitrogenase by purified FeMo-co in extracts of UW45 and UW146 strains


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 6.   Time course of apodinitrogenase activation by purified FeMo-co in extracts of UW45 (nifB) () and UW146 (nifBnafY) (open circle ) strains. The reaction mixture contained 0.7 ml of Tris·HCl buffer, 1.4 ml of UW45 or UW146 cell-free extracts (approx 21 mg of protein), and purified FeMo-co in N-methylformamide (equivalent to 3.5 nmol of molybdenum). At the times indicated, 0.2-ml aliquots (approx 2 mg of protein) were removed from the mixture and treated as described under "Experimental Procedures." Data shown are representative of a number of experiments, which showed very similar results.


    CONCLUSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
CONCLUSION
REFERENCES

In vitro studies with A. vinelandii crude extracts showing that the gamma  protein is able to bind either to free FeMo-co or to apodinitrogenase, and to dissociate from the alpha 2beta 2 subunits after holodinitrogenase reconstitution, led to the proposal of a chaperone insertase role for gamma  (13). In this study, we have cloned the gene encoding gamma , termed nafY, and showed that it encodes a NifY-like protein. Based on sequence and functional similarities, the existence of a NafY/NifY/NifX/VnfX family of iron and molybdenum (or vanadium) cluster-binding proteins is proposed. By mutational inactivation of genes of this family, we have established that both gamma  and NifX are playing a role important for diazotrophic growth when culturing conditions are set to simulate a real environmental situation, in which molybdenum limitation is likely to occur and be of physiological relevance. In principle, that role could be the stabilization of apodinitrogenase or a role during FeMo-co insertion. In vitro FeMo-co insertion experiments indicate that gamma  stabilizes apodinitrogenase in the conformation required for being fully activable by the cofactor. However, the data presented in this study do not support an essential role for gamma  as a FeMo-co insertase and concur with the results of Christiansen et al. (14), which showed that a His-tagged gamma -deficient apodinitrogenase could be activated by the simple addition of FeMo-co. The relationship between the metal cluster binding capabilities of this new family of proteins and their ability to stabilize an apoenzyme has yet to be explained.

    ACKNOWLEDGEMENTS

We thank Dr. Jon Roll for providing partially purified hexameric apodinitrogenase and Dr. Que Lan for help with the Northern analysis. We also thank Dr. Carmen Rüttimann-Johnson, Dr. Chris Staples, and Dr. Vinod K. Shah for helpful discussions. Thanks to Carolyn Brown for help with growth of various A. vinelandii strains. We especially thank Professor Dennis Dean for providing some plasmids, A. vinelandii strains, and for helpful discussions.

    FOOTNOTES

* This work was supported by Grant 35332 from the NIGMS, National Institutes of Health (to P. W. L.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AF302049.

Present address: Corixa Corporation, Seattle, WA 98104.

|| To whom correspondence should be addressed: Dept. of Biochemistry, 433 Babcock Dr., University of Wisconsin-Madison, Madison, WI 53706. Tel.: 608-262-6859; Fax: 608-262-3453; E-mail: pludden@cals.wisc.edu.

Published, JBC Papers in Press, January 31, 2002, DOI 10.1074/jbc.M107289200

2 P. J. Goodwin, D. R. Dean, and C. Rüttimann-Johnson, personal communications.

3 M. J. Homer and G. P. Roberts, unpublished results.

    ABBREVIATIONS

The abbreviations used are: FeMo-co, iron-molybdenum cofactor; FeFe-co, iron-only cofactor; FeV-co, iron-vanadium cofactor; kbp, kilobase pair(s); ORF, open reading frame.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
CONCLUSION
REFERENCES

1. Bulen, W. A., and LeComte, J. R. (1966) Proc. Natl. Acad. Sci. U. S. A. 56, 979-986[Free Full Text]
2. Hageman, R. V., and Burris, R. H. (1978) Proc. Natl. Acad. Sci. U. S. A. 75, 2699-2702[Abstract/Free Full Text]
3. Kim, J., and Rees, D. C. (1992) Nature 360, 553-560[CrossRef]
4. Chan, M. K., Kim, J., and Rees, D. C. (1993) Science 260, 792-794[Abstract/Free Full Text]
5. Georgiadis, M. M., Komiya, H., Chakrabarti, P., Woo, D., Kornuc, J. J., and Rees, D. C. (1992) Science 257, 1653-1659[Abstract/Free Full Text]
6. Allen, R. M., Chatterjee, R., Madden, M., Ludden, P. W., and Shah, V. K. (1994) Crit. Rev. Biotech. 14, 225-249[Medline] [Order article via Infotrieve]
7. Ugalde, R. A., Imperial, J., Shah, V. K., and Brill, W. J. (1984) J. Bacteriol. 159, 888-893[Abstract/Free Full Text]
8. Shah, V. K., Rangaraj, P., Chatterjee, R., Allen, R. M., Roll, J. T., Roberts, G. P., and Ludden, P. W. (1999) J. Bacteriol. 181, 2797-2801[Abstract/Free Full Text]
9. Paustian, T. D., Shah, V. K., and Roberts, G. P. (1990) Biochemistry 29, 3515-3522[CrossRef][Medline] [Order article via Infotrieve]
10. Homer, M. J., Paustian, T. D., Shah, V. K., and Roberts, G. P. (1993) J. Bacteriol. 175, 4907-4910[Abstract/Free Full Text]
11. Robinson, A. C., Chun, T. W., Li, J.-G., and Burgess, B. K. (1989) J. Biol. Chem. 264, 10088-10095[Abstract/Free Full Text]
12. Allen, R. M., Homer, M. J., Chatterjee, R., Ludden, P. W., Roberts, G. P., and Shah, V. K. (1993) J. Biol. Chem. 268, 23670-23674[Abstract/Free Full Text]
13. Homer, M. J., Dean, D. R., and Roberts, G. P. (1995) J. Biol. Chem. 270, 24745-24752[Abstract/Free Full Text]
14. Christiansen, J., Goodwin, P. J., Lanzilotta, W. N., Seefeldt, L. C., and Dean, D. R. (1998) Biochemistry 37, 12611-12623[CrossRef][Medline] [Order article via Infotrieve]
15. White, T. C., Harris, G. S., and Orme-Johnson, W. H. (1992) J. Biol. Chem. 267, 24007-24016[Abstract/Free Full Text]
16. Jacobson, M. R., Brigle, K. E., Bennett, L. T., Setterquist, R. A., Wilson, M. S., Cash, V. L., Beynon, J., Newton, W. E., and Dean, D. R. (1989) J. Bacteriol. 171, 1017-1027[Abstract/Free Full Text]
17. Joerger, R. D., and Bishop, P. E. (1988) J. Bacteriol. 170, 1475-1487[Abstract/Free Full Text]
18. Shah, V. K., Davis, L. C., and Brill, W. J. (1972) Biochim. Biophys. Acta 256, 498-511[Medline] [Order article via Infotrieve]
19. Ausubel, F. N., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. (eds) (2000) Current Protocols in Molecular Biology , Wiley Interscience, New York
20. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990) J. Mol. Biol. 215, 403-410[CrossRef][Medline] [Order article via Infotrieve]
21. Jacobson, M. R., Premakumar, R., and Bishop, P. E. (1986) J. Bacteriol. 167, 480-486[Abstract/Free Full Text]
22. Page, W. J., and von Tigerstrom, M. (1979) J. Bacteriol. 139, 1058-1061[Abstract/Free Full Text]
23. Jacobson, M. R., Cash, V. L., Weiss, M. C., Laird, N. F., Newton, W. E., and Dean, D. R. (1989) Mol. Gen. Genet. 219, 49-57[Medline] [Order article via Infotrieve]
24. Shah, V. K., and Brill, W. J. (1973) Biochim. Biophys. Acta 305, 445-454[Medline] [Order article via Infotrieve]
25. Shah, V. K., and Brill, W. J. (1977) Proc. Natl. Acad. Sci. U. S. A. 74, 3249-3253[Abstract/Free Full Text]
26. Shah, V. K., Ugalde, R. A., Imperial, J., and Brill, W. J. (1985) J. Biol. Chem. 260, 3891-3894[Abstract/Free Full Text]
27. Laemmli, U. K. (1970) Nature 227, 680-685[CrossRef][Medline] [Order article via Infotrieve]
28. Brandner, J. P., McEwan, A. G., Kaplan, S., and Donohue, T. J. (1989) J. Bacteriol. 171, 360-368[Abstract/Free Full Text]
29. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985) Anal. Biochem. 150, 76-85[CrossRef][Medline] [Order article via Infotrieve]
30. Schmehl, M., Jahn, A., Meyer zu Vilsendorf, A., Hennecke, S., Masepohl, B., Schuppler, M., Marxer, M., Oelze, J., and Klipp, W. (1993) Mol. Gen. Genet. 241, 602-615[CrossRef][Medline] [Order article via Infotrieve]
31. Kumagai, H., Fujiwara, T., Matsubara, H., and Saeki, K. (1997) Biochemistry 36, 5509-5521[CrossRef][Medline] [Order article via Infotrieve]
32. Rüttimann-Johnson, C., Staples, C. R., Rangaraj, P., Shah, V. K., and Ludden, P. W. (1999) J. Biol. Chem. 274, 18087-18092[Abstract/Free Full Text]
33. Robson, R. L., Eady, R. R., Richardson, T. H., Miller, R. W., Hawkins, M., and Postgate, J. R. (1986) Nature 322, 388-390[CrossRef]
34. Bishop, P. E., and Joerger, R. D. (1990) Annu. Rev. Plant Physiol. Plant Mol. Biol. 41, 109-125[CrossRef]
35. Shah, V. K., Allen, J. R., Spangler, N. J., and Ludden, P. W. (1994) J. Biol. Chem. 269, 1154-1158[Abstract/Free Full Text]
36. Moreno-Vivian, C., Schmehl, M., Masepohl, B., Arnold, W., and Klipp, W. (1989) Mol. Gen. Genet. 216, 353-363[CrossRef][Medline] [Order article via Infotrieve]
37. Rangaraj, P., Ruttimann-Johnson, C., Shah, V. K., and Ludden, P. W. (2001) J. Biol. Chem. 276, 15968-15974[Abstract/Free Full Text]
38. Frey, J., and Krisch, H. M. (1985) Gene (Amst.) 36, 143-150[CrossRef][Medline] [Order article via Infotrieve]
39. Shah, V. K., Ugalde, R. A., Imperial, J., and Brill, W. J. (1984) Annu. Rev. Biochem. 53, 231-257[Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. Zhao, L. Curatti, and L. M. Rubio
Evidence for nifU and nifS Participation in the Biosynthesis of the Iron-Molybdenum Cofactor of Nitrogenase
J. Biol. Chem., December 21, 2007; 282(51): 37016 - 37025.
[Abstract] [Full Text] [PDF]